Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis

Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis

Systemic reactive AA amyloidosis is a life-threatening complication of chronic inflammatory diseases. Anti-interleukin-6 receptor, tocilizumab (TCZ), has been shown to improve clinical symptoms of patients with AA amyloidosis, accompanied with regression of the amyloid deposition. We report a case o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Masaru Matsui, Satoshi Okayama, Hideo Tsushima, Kenichi Samejima, Tomoko Kanki, Ayako Hasegawa, Katsuhiko Morimoto, Yasuhiro Akai, Masato Takano, Shiro Uemura, Chiho Ohbayashi, Yoshihiko Saito
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Case Reports in Nephrology
Online Access:	http://dx.doi.org/10.1155/2014/823093
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Three Different Morphologies of Inferior Vena Cava Thrombosis: Case Reports
by: Satoshi Okayama, et al.
Published: (2014-01-01)

Recent Insights into the Pathogenesis of Type AA Amyloidosis
by: J. C. H. van der Hilst
Published: (2011-01-01)

AA amyloidosis in adult-onset Still's disease
by: Yuri Vladimirovich Muravye, et al.
Published: (2011-06-01)

Cyclic neutropenia complicated by renal AA amyloidosis
by: A Metin, et al.
Published: (2000-01-01)

Concurrent extramedullary hematopoiesis and AA amyloidosis in the kidney
by: Özant Helvaci, et al.
Published: (2025-03-01)

Polymorphisms in SAA alter intrarenal amyloid distribution of AA amyloidosis in cats
by: Natsumi Kobayashi, et al.
Published: (2025-07-01)

Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
by: H Mihels
Published: (2004-08-01)

WCN25-2218 IL-17A IN AA AMYLOIDOSIS
by: Bollam Prathyusha, et al.
Published: (2025-02-01)

Clinical features of ankylosing spondylitis in patients with secondary AA amyloidosis
by: D. G. Rumyantseva, et al.
Published: (2020-09-01)

Frequency and clinical and laboratory features of ankylosing spondylitis with secondary AA-amyloidosis
by: Ksenia V. Sakharova, et al.
Published: (2025-01-01)

A CASE OF LATE DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER COMPLICATED BY AA-AMYLOIDOSIS
by: S. I. Shchadneva, et al.
Published: (2018-11-01)

WCN25-399 CLINICAL PROFILE AND OUTCOME OF AA AMYLOIDOSIS IN INDIAN PATIENTS
by: Akash Sarkar, et al.
Published: (2025-02-01)

New trends in AA amyloidosis with renal involvement: a single-center experience
by: Nídia Marques, et al.
Published: (2025-02-01)

The Influence of Effective Energy on Computed Tomography Number Depends on Tissue Characteristics in Monoenergetic Cardiac Imaging
by: Satoshi Okayama, et al.
Published: (2012-01-01)

AA-amyloidosis prevalence in rheumatic diseases (according to data of SI Institute of Rheumatology RAMS)
by: Y. V. Muravyov, et al.
Published: (2004-06-01)

An Unusual Cause of Renal Dysfunction: AA Amyloidosis with a Heterozygous Mutation of MEFV Gene
by: Vathul B. Subramanian, et al.
Published: (2025-04-01)

Idiopathic AA amyloidosis presenting with initial abdominal pain: a case report and literature review
by: Pianpian Xia, et al.
Published: (2025-08-01)

Reversible Improvement of Arterial Stenosis and Wall Thickness in Takayasu Arteritis Through Treatment With Tocilizumab
by: Shinichi Nogi, et al.
Published: (2022-11-01)

CASE OF LEFLUNOMIDE-INDUCED CLINICAL AND MORPHOLOGICAL REGRESSION OF AA-AMYLOIDOSIS AND REMISSION OF ADULT-ONSET STILL'S DISEASE
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)

Significance of SAA1 gene polymorphism in the development of AA amyloidosis in patients with rheumatoid arthritis in the Moscow population
by: V A Myakotkin, et al.
Published: (2012-08-01)

Clinical case of SARS-CoV-2 infection in a patient with rheumatoid arthritis and secondary AA-amyloidosis of the lungs
by: O. V. Vorobeva, et al.
Published: (2023-02-01)

WCN25-1300 WHEN HEART IS NOT THE ONLY CULPRIT: A CASE OF AA AMYLOIDOSIS WITH HYPOTENSION IN A YOUNG PATIENT WITH ABDOMINAL TUBERCULOSIS
by: Nidhi Gupta, et al.
Published: (2025-02-01)

A Case of Conjunctival Amyloidosis with Repeated Subconjunctival Hemorrhage
by: Takaaki Ando, et al.
Published: (2017-01-01)

Surgical strategies for localized colorectal amyloidosis
by: Shunya Tahara, et al.
Published: (2023-04-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2016-02-01)

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
by: Nadia K. Rafiq, et al.
Published: (2018-01-01)

Use of tocilizumab for rheumatoid arthritis: new evidence
by: Evgeny Lvovich Nasonov
Published: (2011-12-01)

Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors
by: V. I. Petrov, et al.
Published: (2022-04-01)

A spectacular effect of tocilizumab in Takayasu arteritis
by: Fatma Saïd, et al.
Published: (2024-11-01)

Tracheobronchial amyloidosis
by: Khalil Jivraj, et al.
Published: (2014-01-01)

Tracheal amyloidosis
by: Ruwan Amaratunga, et al.
Published: (2014-01-01)

A clinical case of development of Waterhouse-Friderichsen syndrome after SARS-CoV-2 infection in a patient with rheumatoid arthritis and secondary adrenal AA-amyloidosis
by: O. V. Alpidovskaya
Published: (2023-08-01)

Experience of the Tocilizumab Application in Systemic Onset Juvenile Arthritis
by: A. V. Krasnopol’skaja, et al.
Published: (2015-11-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)

Efficacy of tocilizumab in resistant forms of Thyroid Eye Disease
by: Marković Bojan, et al.
Published: (2025-01-01)

Lack of efficacy of tocilizumab in acute exacerbation of pulmonary fibrosis
by: Giovanni Franco, et al.
Published: (2024-12-01)

Tocilizumab in COVID-19: A Double-Edged Sword?
by: Bartosz Kudliński, et al.
Published: (2024-12-01)

Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro
by: Miyako Shimasaki, et al.
Published: (2024-12-01)

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)